This study evaluated the motor and sensory block durations and the postoperative analgesic effects of adding Magnesium Sulphate to Bupivacaine HCL for Ultrasound-guided supraclavicular brachial plexus block. Sixty ASA I-II patients subjected to elective forearm or hand surgery were randomly divided equally into 1 of 2 groups depending upon the local anesthesia (LA) solution used to receive either 23 mL of bupivacaine HCL 0.5% plus 2 mL normal saline (group B) or 23 mL of bupivacaine HCL 0.5% plus Magnesium Sulphate 100 mg diluted with 2mL normal saline (group BM). Motor and sensory block durations were evaluated until the return of normal motor and sensory function. The degree of pain was assessed during the surgery period and 24 hours postoperatively. The results of this study showed that Magnesium Sulphate provided significantly longer motor block duration (329.33 ± 86.54 min vs 237.46 ± 62.91 min, P = 0.001) and significantly longer sensory block duration (356.00 ± 117.02 min vs 278.00 ± 87.23 min, P = 0.005) when compared with bupivacaine alone. Furthermore, the patients in the Magnesium Sulphate group achieved significantly (P < 0.001) lower values of Visual Analogue Scale (VAS) of pain between the periods from 4 to 12 hours postoperatively. There was significantly less diclofenac consumed (mg) in the Magnesium Sulphate group. The patients in the Magnesium Sulphate group reported significantly higher rates of good sleep quality on the first postoperative night (75%) compared with the patients in the bupivacaine group (25%). Also, the patient satisfaction was significantly higher in the Magnesium Sulphate group compared with the bupivacaine group (75% vs 25%). We concluded that Magnesium Sulphate 100 mg to bupivacaine HCL extended the motor and sensory block durations, provided more effective postoperative analgesia with improvement in the sleep quality of the first postoperative night, and provided better patient satisfaction compared to bupivacaine HCL alone.
Published in | International Journal of Anesthesia and Clinical Medicine (Volume 7, Issue 1) |
DOI | 10.11648/j.ijacm.20190701.13 |
Page(s) | 13-19 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2019. Published by Science Publishing Group |
Magnesium Sulphate, Supraclavicular Brachial Plexus Block Anesthesia
[1] | Neal JM, Gerancher JC, Hebl JR, et al. Upper extremity regional anesthesia: essentials of our current understanding. Reg Anesth Pain Med 2009 Mar-Apr; 34 (2): 134-70. |
[2] | Rana S, Verma RK, Singh J, Chaudhary SK, Chandel A. Magnesium sulphate as an adjuvant to bupivacaine in ultrasound-guided transversus abdominis plane block in patients scheduled for total abdominal hysterectomy under subarachnoid block. Indian J Anaesth. 2016 Mar; 60 (3): 174-9. |
[3] | Verma V, Rana S, Chaudhary SK, Singh J, Verma RK, Sood S. A dose-finding randomised controlled trial of magnesium sulphate as an adjuvant in ultrasound-guided supraclavicular brachial plexus block. Indian J Anaesth. 2017 Mar; 61 (3): 250-255. |
[4] | Li M, Jin S, Zhao X, Xu Z, Ni X, Zhang L, Liu Z. Does Magnesium Sulfate as an Adjuvant of Local Anesthetics Facilitate Better Effect of Perineural Nerve Blocks? A Meta-analysis of Randomized Controlled Trials. Clin J Pain. 2016 Dec; 32 (12): 1053-1061. |
[5] | Bailard NS, Ortiz J, Flores RA. Additives to local anesthetics for peripheral nerve blocks: Evidence, limitations, and recommendations. Am J Health Syst Pharm. 2014 Mar 1; 71 (5): 373-85. |
[6] | Wiles MD, Nathanson MH. Local anaesthetics and adjuvants--future developments. Anaesthesia. 2010 Apr; 65 Suppl 1: 22-37. |
[7] | Albrecht E, Kirkham KR, Liu SS, Brull R. The analgesic efficacy and safety of neuraxial magnesium sulphate: a quantitative review. Anaesthesia. 2013 Feb; 68 (2): 190-202. |
[8] | Lee AR, Yi HW, Chung IS, Ko JS, Ahn HJ, Gwak MS, Choi DH, Choi SJ. Magnesium added to bupivacaine prolongs the duration of analgesia after interscalene nerve block. Can J Anaesth. 2012 Jan; 59 (1): 21-7. |
[9] | Woolf CJ, Thompson SW. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain. 1991 Mar; 44 (3): 293-9. |
[10] | Carney CE, Buysse DJ, Ancoli-Israel S, Edinger JD, Krystal AD, Lichstein KL, Morin CM. The consensus sleep diary: standardizing prospective sleep self-monitoring. Sleep. 2012 Feb 1; 35 (2): 287-302. |
[11] | Li M, Jin S, Zhao X, Xu Z, Ni X, Zhang L, et al. Does Magnesium Sulfate as an Adjuvant of Local Anesthetics Facilitate Better Effect of Perineural Nerve Blocks?. Clin J Pain. 2016 Dec; 32 (12): 1053-1061. |
[12] | Haghighi M, Soleymanha M, Sedighinejad A, Mirbolook A, Nabi BN, Rahmati M, et al. The effect of magnesium sulfate on motor and sensory axillary plexus blockade. Anesth Pain Med. 2015 Feb; 5 (1). |
[13] | Ekmekci P, Bengisun ZK, Akan B, Kazbek BK, Ozkan KS, Suer AH. The effect of magnesium added to levobupivacaine for femoral nerve block on postoperative analgesia in patients undergoing ACL reconstruction. Knee Surg Sports Traumatol Arthrosc. 2013 May; 21 (5): 1119-24. |
[14] | Mukherjee K, Das A, Basunia SR, Dutta S, Mandal P, Mukherjee A. Evaluation of Magnesium as an adjuvant in Ropivacaine-induced supraclavicular brachial plexus block: A prospective, double-blinded randomized controlled study. Journal of research in pharmacy practice 2014 Oct-Dec; 3 (4): 123–129. |
[15] | Gunduz A, Bilir A, Gulec S. Magnesium added to prilocaine prolongs the duration of axillary plexus block. Reg Anesth Pain Med. 2006 May-Jun; 31 (3): 233-6. |
[16] | Koinig H, Wallner T, Marhofer P, Andel H, Horauf K, Mayer N. Magnesium sulfate reduces intra-and postoperative analgesic requirements. Anesth Analg. 1998 Jul; 87 (1): 206-10. |
[17] | Woolf CJ, Thompson SW. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain. 1991 Mar; 44 (3): 293-9. |
[18] | Urch CE, Rahman W, Dickenson AH. Electrophysiological studies on the role of the NMDA receptor in nociception in the developing rat spinal cord. Brain Res Dev Brain Res. 2001 Jan 31; 126 (1): 81-9. |
[19] | Liu HT, Hollmann MW, Liu WH, Hoenemann CW, Durieux ME. Modulation of NMDA receptor function by ketamine and magnesium: Part I. Anesth Analg. 2001 May; 92 (5): 1173-81. |
[20] | Miranda HF, Bustamante D, Kramer V, Pelissier T, Saavedra H, Paeile C, et al. Antinociceptive effects of Ca2+ channel blockers. Eur J Pharmacol. 1992 Jul 7; 217 (2-3): 137-41. |
APA Style
Ashraf Mohamed Ghali, Khalid Mohamad Awid Molokhia, Sameh Abdelkhalik Ahmed. (2019). The Effect on Outcome of Adding Magnesium Sulphate to Bupivacaine in the Ultrasound-guided Supraclavicular Brachial Plexus Block Anesthesia. International Journal of Anesthesia and Clinical Medicine, 7(1), 13-19. https://doi.org/10.11648/j.ijacm.20190701.13
ACS Style
Ashraf Mohamed Ghali; Khalid Mohamad Awid Molokhia; Sameh Abdelkhalik Ahmed. The Effect on Outcome of Adding Magnesium Sulphate to Bupivacaine in the Ultrasound-guided Supraclavicular Brachial Plexus Block Anesthesia. Int. J. Anesth. Clin. Med. 2019, 7(1), 13-19. doi: 10.11648/j.ijacm.20190701.13
AMA Style
Ashraf Mohamed Ghali, Khalid Mohamad Awid Molokhia, Sameh Abdelkhalik Ahmed. The Effect on Outcome of Adding Magnesium Sulphate to Bupivacaine in the Ultrasound-guided Supraclavicular Brachial Plexus Block Anesthesia. Int J Anesth Clin Med. 2019;7(1):13-19. doi: 10.11648/j.ijacm.20190701.13
@article{10.11648/j.ijacm.20190701.13, author = {Ashraf Mohamed Ghali and Khalid Mohamad Awid Molokhia and Sameh Abdelkhalik Ahmed}, title = {The Effect on Outcome of Adding Magnesium Sulphate to Bupivacaine in the Ultrasound-guided Supraclavicular Brachial Plexus Block Anesthesia}, journal = {International Journal of Anesthesia and Clinical Medicine}, volume = {7}, number = {1}, pages = {13-19}, doi = {10.11648/j.ijacm.20190701.13}, url = {https://doi.org/10.11648/j.ijacm.20190701.13}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijacm.20190701.13}, abstract = {This study evaluated the motor and sensory block durations and the postoperative analgesic effects of adding Magnesium Sulphate to Bupivacaine HCL for Ultrasound-guided supraclavicular brachial plexus block. Sixty ASA I-II patients subjected to elective forearm or hand surgery were randomly divided equally into 1 of 2 groups depending upon the local anesthesia (LA) solution used to receive either 23 mL of bupivacaine HCL 0.5% plus 2 mL normal saline (group B) or 23 mL of bupivacaine HCL 0.5% plus Magnesium Sulphate 100 mg diluted with 2mL normal saline (group BM). Motor and sensory block durations were evaluated until the return of normal motor and sensory function. The degree of pain was assessed during the surgery period and 24 hours postoperatively. The results of this study showed that Magnesium Sulphate provided significantly longer motor block duration (329.33 ± 86.54 min vs 237.46 ± 62.91 min, P = 0.001) and significantly longer sensory block duration (356.00 ± 117.02 min vs 278.00 ± 87.23 min, P = 0.005) when compared with bupivacaine alone. Furthermore, the patients in the Magnesium Sulphate group achieved significantly (P < 0.001) lower values of Visual Analogue Scale (VAS) of pain between the periods from 4 to 12 hours postoperatively. There was significantly less diclofenac consumed (mg) in the Magnesium Sulphate group. The patients in the Magnesium Sulphate group reported significantly higher rates of good sleep quality on the first postoperative night (75%) compared with the patients in the bupivacaine group (25%). Also, the patient satisfaction was significantly higher in the Magnesium Sulphate group compared with the bupivacaine group (75% vs 25%). We concluded that Magnesium Sulphate 100 mg to bupivacaine HCL extended the motor and sensory block durations, provided more effective postoperative analgesia with improvement in the sleep quality of the first postoperative night, and provided better patient satisfaction compared to bupivacaine HCL alone.}, year = {2019} }
TY - JOUR T1 - The Effect on Outcome of Adding Magnesium Sulphate to Bupivacaine in the Ultrasound-guided Supraclavicular Brachial Plexus Block Anesthesia AU - Ashraf Mohamed Ghali AU - Khalid Mohamad Awid Molokhia AU - Sameh Abdelkhalik Ahmed Y1 - 2019/03/05 PY - 2019 N1 - https://doi.org/10.11648/j.ijacm.20190701.13 DO - 10.11648/j.ijacm.20190701.13 T2 - International Journal of Anesthesia and Clinical Medicine JF - International Journal of Anesthesia and Clinical Medicine JO - International Journal of Anesthesia and Clinical Medicine SP - 13 EP - 19 PB - Science Publishing Group SN - 2997-2698 UR - https://doi.org/10.11648/j.ijacm.20190701.13 AB - This study evaluated the motor and sensory block durations and the postoperative analgesic effects of adding Magnesium Sulphate to Bupivacaine HCL for Ultrasound-guided supraclavicular brachial plexus block. Sixty ASA I-II patients subjected to elective forearm or hand surgery were randomly divided equally into 1 of 2 groups depending upon the local anesthesia (LA) solution used to receive either 23 mL of bupivacaine HCL 0.5% plus 2 mL normal saline (group B) or 23 mL of bupivacaine HCL 0.5% plus Magnesium Sulphate 100 mg diluted with 2mL normal saline (group BM). Motor and sensory block durations were evaluated until the return of normal motor and sensory function. The degree of pain was assessed during the surgery period and 24 hours postoperatively. The results of this study showed that Magnesium Sulphate provided significantly longer motor block duration (329.33 ± 86.54 min vs 237.46 ± 62.91 min, P = 0.001) and significantly longer sensory block duration (356.00 ± 117.02 min vs 278.00 ± 87.23 min, P = 0.005) when compared with bupivacaine alone. Furthermore, the patients in the Magnesium Sulphate group achieved significantly (P < 0.001) lower values of Visual Analogue Scale (VAS) of pain between the periods from 4 to 12 hours postoperatively. There was significantly less diclofenac consumed (mg) in the Magnesium Sulphate group. The patients in the Magnesium Sulphate group reported significantly higher rates of good sleep quality on the first postoperative night (75%) compared with the patients in the bupivacaine group (25%). Also, the patient satisfaction was significantly higher in the Magnesium Sulphate group compared with the bupivacaine group (75% vs 25%). We concluded that Magnesium Sulphate 100 mg to bupivacaine HCL extended the motor and sensory block durations, provided more effective postoperative analgesia with improvement in the sleep quality of the first postoperative night, and provided better patient satisfaction compared to bupivacaine HCL alone. VL - 7 IS - 1 ER -